Brain or B type natriuretic peptide is increasingly used as
a marker of congestive
heart failure. It has
high specificity for the condition. It is released by ventricular cardiomyocytes
due to stretch as part of the
pathophysiology of cardiac failure.
GIIB/IIIA inhibitors such as Reopro or
Tirofibran have a treatment role in NSTEMI
No comments:
Post a Comment